Discover
APRE
Aprea Therapeutics, Inc.
0.75
1 x 0.79
2 x 0.86
bid
ask
-
0.06
7.13%
2 @ 07:00 AM
0.77 +0.02 (2.70%)
| Ytd | -12.65% | |
| 1y | -54.84% |
0.71
day range
0.81
0.55
52 week range
2.22
| Open | 0.80 | Prev Close | 0.80 | Low | 0.71 | High | 0.81 | Mkt Cap | 9.23M |
| Vol | 165.46K | Avg Vol | 209.35K | EPS | -1.49 | P/E | N/A | Forward P/E | -3.08 |
| Beta | 1.74 | Short Ratio | 0.55 | Inst. Own | 43.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.83 | 200-d Avg | 0.98 | 1yr Est | 15.67 |
| Income Statement | |||
| Operating Expenses | 3.43M | ||
| Research and Development Expense | 1.61M | ||
| Selling, General and Administrative Expense | 1.82M | ||
| Operating Income | -3.43M | ||
| Interest Expense | -134.78K | ||
| Net Income | -3.29M | ||
| Net Income Common Stock | -3.29M | ||
| Net Income Common Stock (USD) | -3.29M | ||
| Consolidated Income | -3.29M | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -3.42M | ||
| Earning Before Interest & Taxes (USD) | -3.42M | ||
| Weighted Average Shares | 14.69M | ||
| Weighted Average Shares Diluted | 14.69M | ||
| Balance Sheet | |||
| Cash and Equivalents | 46.51M | ||
| Cash and Equivalents (USD) | 46.51M | ||
| Current Assets | 47.25M | ||
| Property, Plant & Equipment Net | 54.38K | ||
| Total Assets | 47.61M | ||
| Current Liabilities | 5.30M | ||
| Total Liabilities | 6.02M | ||
| Accumulated Retained Earnings (Deficit) | -336.93M | ||
| Accumulated Other Comprehensive Income | -10.63M | ||
| Shareholders Equity | 41.59M | ||
| Shareholders Equity (USD) | 41.59M | ||
| Assets Non-Current | 366.95K | ||
| Liabilities Non-Current | 727.36K | ||
| Trade and Non-Trade Payables | 2.94M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.43K | ||
| Net Cash Flow from Financing | 34.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 31.87M | ||
| Issuance (Purchase) of Equity Shares | 34.62M | ||
| Net Cash Flow from Operations | -2.76M | ||
| Effect of Exchange Rate Changes on Cash | -348.00 | ||
| Share Based Compensation | 101.07K | ||